Action observation and motor image… for Parkinson's (NCT06154356)

Improve balance with motor imagery

Trial ID
NCT06154356
Official Title
Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Parkinson's Disease, Randomized Controlled Trial
Goal
Improve balance with motor imagery
Phase
NA
Status
RECRUITING
Sponsor
Karamanoğlu Mehmetbey University
Study Type
INTERVENTIONAL
Enrollment
54 participants
Conditions
Parkinson's Disease
Interventions
Action observation and motor imagery therapy for rehabilitation, Sham action observation and motor imagery therapy for rehabilitation

Summary For Families

They are testing whether watching everyday movements and mentally rehearsing them can improve balance, daily function, and overall quality of life for people with Parkinson's. The therapy uses action observation and motor imagery, meaning you watch actions and vividly imagine doing them to activate the brain's motor networks and strengthen motor planning and balance without physical strain, while a sham version uses non-matching or neutral stimuli as a control. Because it is a non-drug, brain-based rehearsal method, it can complement usual physical therapy and be used alongside Parkinson's medications. The trial is looking for adults 18 to 65 with Parkinson's at Hoehn and Yahr stages 1 to 3 who can follow simple instructions, and it excludes people with major cognitive, severe vision or hearing problems, uncontrolled heart or lung disease, or musculoskeletal issues that limit movement.

Locations

  • Karaman Training and Research Hospital, Karaman, Karaman, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Action observation and motor imagery therapy for rehabilitation. They are testing whether watching everyday movements and mentally rehearsing them can improve balance, daily function, and overall quality of life for people with Parkinson's. The therapy uses action observation and motor imagery, meaning you watch actions and vividly imagine doing them to activate the brain's motor networks and strengthen motor planning and balance without physical strain, while a sham version uses non-matching or neutral stimuli as a control. Because it is a non-drug, brain-based rehearsal method, it can complement usual physical therapy and be used alongside Parkinson's medications. The trial is looking for adults 18 to 65 with Parkinson's at Hoehn and Yahr stages 1 to 3 who can follow simple instructions, and it excludes people with major cognitive, severe vision or hearing problems, uncontrolled heart or lung disease, or musculoskeletal issues that limit movement.
Who can participate?
Participants must be between 18 Years and 65 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
How long does the trial last?
This trial is estimated to last approximately 2 years and 6 months.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
This trial has 2 groups, and 1 is a sham (a pretend version of the procedure) group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the sham group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.

Related Reading

View on ClinicalTrials.gov